home / stock / bmy / bmy news


BMY News and Press, Bristol-Myers Squibb Company From 04/23/24

Stock Information

Company Name: Bristol-Myers Squibb Company
Stock Symbol: BMY
Market: NYSE
Website: bms.com

Menu

BMY BMY Quote BMY Short BMY News BMY Articles BMY Message Board
Get BMY Alerts

News, Short Squeeze, Breakout and More Instantly...

BMY - Baron Health Care Fund Q1 2024 Shareholder Letter

2024-04-23 09:30:00 ET Summary Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. In the quarter ended March 31, 2024, Baron Health Care Fund advanced 8.92% compared wi...

BMY - Gilead Q1 Earnings Preview: Most Gains Wiped Out - Cause For Concern?

2024-04-23 09:00:03 ET Summary GILD stock has given up most of its late-2022 gains due to sector-wide underperformance and disappointing data from the EVOKE-01 Phase 3 trial. Gilead Sciences will report its Q1 2024 earnings on Thursday, April 25. Hence, and considering my last art...

BMY - Bristol Myers, Cellares ink $380M CAR-T therapies supply deal

2024-04-22 09:51:41 ET Bristol Myers Squibb ( NYSE: BMY ) on Monday announced a $380M deal with contract manufacturer Cellares to produce CAR T cell therapies.... Read the full article on Seeking Alpha For further details see: Bristol Myers, Cellares ink $380M CA...

BMY - Is Bristol Myers Squibb A Buy At These Bottom Levels?

2024-04-22 09:30:00 ET Summary BMY has been upgraded to a Buy, with the stock already yielding 5.02% at the time of writing and the Seeking Alpha Quant still grading its dividend safety at B-. Combined with the promising profitability metrics and its overly discounted valuations, ...

BMY - Bristol Myers Squibb and Cellares Announce a $380M Worldwide Capacity Reservation and Supply Agreement for the Manufacture of CAR T Cell Therapies to Bring the Promise of Cell Therapy to More Patients, Faster

Bristol Myers Squibb will utilize Cellares’ proprietary Cell Shuttle, a next-generation end-to-end, fully automated cell therapy manufacturing platform, for the clinical and commercial-scale manufacturing of select CAR T cell therapies Cellares, the world’s first...

BMY - SCHD: If You've Won The Game, Take A Little Off The Top

2024-04-22 00:41:39 ET Summary SCHD is a great capital gains storage for positions that may be getting over-concentrated in your portfolio. Many investors have big winners from buying the dips in 2020 and 2022. Chances are your winners have expanded P/E ratios. SCHD is a great...

BMY - Goldman picks top capex and R&D stocks

2024-04-21 14:42:04 ET More on the markets SPY: Higher For Longer Could Be Good News S&P 500: Positive Outlook, I'm Modifying My Hedge SPY: Resurgent Inflation, Soaring Yields, Geopolitical Turmoil - 1970s All Over Again? Wall Street's April pullback inte...

BMY - High-Quality Dividend Growth Near 52-Week Lows: Apple Is Attractive

2024-04-21 09:36:07 ET Summary A list of high-quality dividend growth stocks trading near 52-week lows is evaluated based on Historical and Future Fair values. Apple appears to be near fair value, and trading near 52-week lows could be at a favorable entry point for long-term inve...

BMY - Earnings week ahead: Tesla, Meta Platforms, Google, Microsoft, Intel, Exxon Mobil, and more

2024-04-21 08:00:00 ET As the market gears up for another eventful earnings week, investors are eagerly anticipating reports from a wide array of companies across various sectors. Big names like Tesla ( NASDAQ: TSLA ), Microsoft ( NASDAQ: MSFT ), Alphabet ( NASDAQ: GOOG ...

BMY - THQ: Collecting A High Yield From Increased Medical Spending

2024-04-20 12:03:00 ET Summary abrdn Healthcare Opportunities Fund (THQ) offers a high dividend yield of 11.3% and exposure to diverse subsectors of the healthcare industry. The fund outperforms its peers, abrdn World Healthcare Fund (THW) and BlackRock's Health Sciences Trust (BM...

Previous 10 Next 10